查詢結果分析
來源資料
頁籤選單縮合
題 名 | 藥物於糖尿病胃輕癱血糖改善評估=The Glycemic Control Effect of Prokinetic Drugs in Patients with Diabetic Gastroparesis |
---|---|
作 者 | 柯姿璇; 葉子慧; 王明賢; 孫淑慧; | 書刊名 | 藥學雜誌 |
卷 期 | 32:1=126 2016.03[民105.03] |
頁 次 | 頁77-81 |
分類號 | 415.52 |
關鍵詞 | 糖尿病性胃輕癱; Diabetic gastroparesis; Prokinetic agents; HbA1c; |
語 文 | 中文(Chinese) |
中文摘要 | 胃腸道蠕動由神經與腸道荷爾蒙所調控,現代醫學對糖尿病性胃輕癱的發病機制 尚未完全闡明,已知應用胃腸蠕動促進劑治療可獲得一定的療效。糖尿病性胃輕癱, 臨床上通常發生在罹有長期的糖尿病人身上,易有胃輕癱現象,長期血糖控制不佳, 併有糖尿病腎病變、周圍神經病變、視網膜病變或是 autonomic neuropathy 的併發症 者;整個糖尿病人族群中,其中第1型糖尿病約有40%、第2型糖尿病約有10-20%病人 有這樣的症狀。 既然糖尿病性胃輕癱是糖尿病人較為常見的併發症,文獻也指出可能與血糖波 動或長期控制不良相關。本篇在於探討每日服用 mosapride 或 metoclopramide 數週後 對糖尿病性胃輕癱患者糖化血色素、血糖值的變化,瞭解 prokinetic agents 能改善腸 胃蠕動,獲得良好消化同時也能配合降血糖用藥 (含胰島素) 之作用而讓病人有較好 之血糖控制從而減少可能導致胃輕癱的致病機轉。相關研究有助於評估 mosapride 與 metoclopramide 在糖尿病性胃輕癱所產生的影響,進而發展出適宜的糖尿病性胃輕癱 臨床治療藥物。本篇透過對 prokinetic agents 深入了解將提供臨床治療糖尿病性胃輕 癱之額外思考。 |
英文摘要 | Gastrointestinal motility is modulated by a complex set of neural and intestinal hormones signal. Modern medicine has not completely clarified the pathogenesis of diabetic gastroparesis, and prokinetic drug may have certain efficacy. Diabetic gastroparesis, with clinically usually occurs in suffering from is a long period of diabetic mellitus (DM), lead to long-term poor glycemic control and complications of diabetes including nephropathy, peripheral neuropathy, retinopathy and autonomic neuropathy. In some reports, symptoms attributable to gastroparesis has been reported 40% in type 1 diabetics and 10-20% in type 2 diabetics. Since diabetic gastroparesis is the most common complication of DM, it may be associated with blood sugar fluctuation or long-term poor glycemic control. The aim of this study is investigated the efficacy of mosapride and metoclopramide for several weeks on glycated hemoglobin, blood glucose concentrations in patients with diabetic gastroparesis. It also helps to figure out whether the prokinetic agents may provide better blood sugar control and reduce the etiological mechanism of gastroparesis due to improvement in motility and digestion. The study is helpful to evaluate the efficacy of mosapride and metoclopramide on diabetic gastroparesis. Owing to comparison of prokinetic agents, this study provides clinical thinking about treating those diabetic gastroparesis patients with long-term poor glycemic control and multiple complications. |
本系統中英文摘要資訊取自各篇刊載內容。